These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30224109)

  • 21. Economic evaluation of genomic sequencing in the paediatric population: a critical review.
    Alam K; Schofield D
    Eur J Hum Genet; 2018 Sep; 26(9):1241-1247. PubMed ID: 29795475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid and affordable genome-wide bisulfite DNA sequencing by XmaI-reduced representation bisulfite sequencing.
    Tanas AS; Borisova ME; Kuznetsova EB; Rudenko VV; Karandasheva KO; Nemtsova MV; Izhevskaya VL; Simonova OA; Larin SS; Zaletaev DV; Strelnikov VV
    Epigenomics; 2017 Jun; 9(6):833-847. PubMed ID: 28488887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whole genome sequencing identifies influenza A H3N2 transmission and offers superior resolution to classical typing methods.
    Meinel DM; Heinzinger S; Eberle U; Ackermann N; Schönberger K; Sing A
    Infection; 2018 Feb; 46(1):69-76. PubMed ID: 29086356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lake Louise mutation detection meeting 2013: clinical translation of next-generation sequencing requires optimization of workflows and interpretation of variants.
    Smith A; Boycott KM; Jarinova O
    Hum Mutat; 2014 Feb; 35(2):265-9. PubMed ID: 24282140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional regression method for whole genome eQTL epistasis analysis with sequencing data.
    Xu K; Jin L; Xiong M
    BMC Genomics; 2017 May; 18(1):385. PubMed ID: 28521784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical pharmacogenomics testing in the era of next generation sequencing: challenges and opportunities for precision medicine.
    Ji Y; Si Y; McMillin GA; Lyon E
    Expert Rev Mol Diagn; 2018 May; 18(5):411-421. PubMed ID: 29634383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controversy and debate on clinical genomics sequencing-paper 1: genomics is not exceptional: rigorous evaluations are necessary for clinical applications of genomic sequencing.
    Wilson BJ; Miller FA; Rousseau F
    J Clin Epidemiol; 2017 Dec; 92():4-6. PubMed ID: 28870871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The promise and challenges of next-generation genome sequencing for clinical care.
    Johansen Taber KA; Dickinson BD; Wilson M
    JAMA Intern Med; 2014 Feb; 174(2):275-80. PubMed ID: 24217348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving hazard characterization in microbial risk assessment using next generation sequencing data and machine learning: Predicting clinical outcomes in shigatoxigenic Escherichia coli.
    Njage PMK; Leekitcharoenphon P; Hald T
    Int J Food Microbiol; 2019 Mar; 292():72-82. PubMed ID: 30579059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Whole-genome sequencing approaches for conservation biology: Advantages, limitations and practical recommendations.
    Fuentes-Pardo AP; Ruzzante DE
    Mol Ecol; 2017 Oct; 26(20):5369-5406. PubMed ID: 28746784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole-genome bisulfite sequencing with improved accuracy and cost.
    Suzuki M; Liao W; Wos F; Johnston AD; DeGrazia J; Ishii J; Bloom T; Zody MC; Germer S; Greally JM
    Genome Res; 2018 Sep; 28(9):1364-1371. PubMed ID: 30093547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative analysis of algorithms for whole-genome assembly of pyrosequencing data.
    Finotello F; Lavezzo E; Fontana P; Peruzzo D; Albiero A; Barzon L; Falda M; Di Camillo B; Toppo S
    Brief Bioinform; 2012 May; 13(3):269-80. PubMed ID: 22021898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimating the costs of genomic sequencing in cancer control.
    Gordon LG; White NM; Elliott TM; Nones K; Beckhouse AG; Rodriguez-Acevedo AJ; Webb PM; Lee XJ; Graves N; Schofield DJ
    BMC Health Serv Res; 2020 Jun; 20(1):492. PubMed ID: 32493298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Whole genome sequencing reveals genomic heterogeneity and antibiotic purification in Mycobacterium tuberculosis isolates.
    Black PA; de Vos M; Louw GE; van der Merwe RG; Dippenaar A; Streicher EM; Abdallah AM; Sampson SL; Victor TC; Dolby T; Simpson JA; van Helden PD; Warren RM; Pain A
    BMC Genomics; 2015 Oct; 16():857. PubMed ID: 26496891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical trial-based cost-effectiveness analyses of antipsychotic use.
    Polsky D; Doshi JA; Bauer MS; Glick HA
    Am J Psychiatry; 2006 Dec; 163(12):2047-56. PubMed ID: 17151153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Valuation of Health and Nonhealth Outcomes from Next-Generation Sequencing: Approaches, Challenges, and Solutions.
    Regier DA; Weymann D; Buchanan J; Marshall DA; Wordsworth S
    Value Health; 2018 Sep; 21(9):1043-1047. PubMed ID: 30224107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of functional disease-causal/susceptible variants identified by whole-genome analyses for the understanding of human diseases.
    Hitomi Y; Tokunaga K
    Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(9):657-676. PubMed ID: 29129848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neisseria genomics: current status and future perspectives.
    Harrison OB; Schoen C; Retchless AC; Wang X; Jolley KA; Bray JE; Maiden MCJ
    Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28591853
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.